Arbutus Biopharma to Reveal Q2 Financials and Corporate Updates

Arbutus Biopharma

WARMINSTER, PAArbutus Biopharma Corporation (Nasdaq: ABUS) has announced its plans to release its second quarter 2024 financial results and provide a corporate update on Thursday, August 1, 2024.

The company will issue its Q2 2024 press release at 7:30 a.m. Eastern Time, followed by a conference call and webcast at 8:45 a.m. Eastern Time. Interested parties can register for the conference call through this link, and the live webcast will be accessible via the Investors section of Arbutus’ website at www.arbutusbio.com.

For those unable to attend the live event, an archived webcast will be available on the Arbutus website after the conference. This update offers a crucial opportunity for investors and analysts to gain insights into the company’s financial health and strategic plans for the near future.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.

READ:  Helius Medical Technologies Seeks Fair Market Access for PoNS Device Amid CMS Pricing Challenges